Rare cause of cardiac failure in an infant

Cláudio Henriques1, Helena Andrade1, António Pires1

  • 1Paediatric Cardiology Department, Paediatric Hospital, Coimbra,Portugal.

Insights

Congenital pulmonary vein stenosis is a rare condition. This case study details a 6-month-old infant experiencing severe narrowing of all four pulmonary veins, highlighting challenges in treatment outcomes.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Medical Case Reports

Background:

  • Congenital stenosis of the pulmonary veins is a rare and serious condition.
  • Outcomes for affected individuals remain guarded despite current therapeutic interventions.

Observation:

  • A 6-month-old infant presented with symptoms indicative of pulmonary venous obstruction.
  • Diagnostic imaging revealed significant stenosis affecting all four pulmonary veins.
  • The infant's clinical condition underscored the severity of the widespread venous narrowing.

Findings:

  • The case involved a rare instance of severe, diffuse congenital pulmonary vein stenosis.
  • The infant exhibited significant hemodynamic compromise due to the widespread obstruction.
  • This presentation emphasizes the challenges in managing extensive CPVS.

Implications:

  • This case underscores the need for improved diagnostic and therapeutic strategies for congenital pulmonary vein stenosis.
  • Further research into the pathophysiology and long-term outcomes of CPVS is warranted.
  • Highlighting such rare cases can improve clinical awareness and management protocols for pediatric cardiovascular conditions.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
757
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
936
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
487